EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come

Panagiota Mavroeidi, Maria Xilouri iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Panagiota Mavroeidi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, …. Hauptthemen laut MEDLINE: Autophagy, Lysosomes, Multiple System Atrophy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation, Multiple System Atrophy UK Trust, Multiple System Atrophy Coalition.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple lines of evidence extracted from human post-mortem brain material and cellular and animal models of concomitant proteinopathies cumulatively suggest that the neuronal protein α-Synuclein exerts a strong influence on the pathogenesis of neurodegenerative comorbidities, collectively termed α-Synucleinopathies. Accumulation of α-Synuclein-positive inclusions in neurons or oligodendrocytes is the main histopathological hallmark of Parkinson’s disease (PD) or multiple system atrophy (MSA), respectively. In addition, various pieces of data indicate that components of the autophagy-lysosomal pathway are altered in the context of α-Synucleinopathies. α-Synuclein itself is degraded by autophagy; however, aberrant protein conformations may impair lysosomal function. Genetic PD often involves components of the lysosome, including common genetic mutations in GBA1, which encodes for the lysosomal enzyme β-glucocerebrosidase. Alterations in lysosomal components that correlate with a commensurate increase in α-Synuclein deposition have been widely observed in PD brains. However, corresponding data in the context of MSA are emerging but remain less extensive than PD. In the current review, we focus on the pathological features as well as the impairments in the autophagy–lysosome pathway (ALP) that are associated with MSA and discuss the current challenges and future directions of therapeutic strategies targeting autophagy in experimental MSA-like models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyLysosomesMultiple System AtrophyHumansAnimalsalpha-SynucleinGlucosylceramidaseSignal TransductionParkinson Disease

Stichwörter der Autor:innen

autophagylysosomesmultiple system atrophy (MSA)neurodegenerationoligodendrocytestherapeuticsα-Synuclein

Substanzen

alpha-SynucleinGlucosylceramidase

Autor:innen und Institutionen

  • Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.

ORCID-Profile: Maria Xilouri

Förderung

  • Hellenic Foundation for Research and Innovation
  • Multiple System Atrophy UK Trust
  • Multiple System Atrophy Coalition
  • Michael J. Fox Foundation
  • Brain Precision Greece 2.0 program

Zitieren

APA

Mavroeidi, P., & Xilouri, M. (2025). Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010204

Vancouver

Mavroeidi P, Xilouri M. Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010204

BibTeX
@article{Mavroeidi2025,
  author = {Mavroeidi, Panagiota and Xilouri, Maria},
  title = {Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010204}
}
Kostenlos starten →